Literature DB >> 6208484

A pathogenic retrovirus (HTLV-III) linked to AIDS.

S Broder, R C Gallo.   

Abstract

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome--etiology; Biology; Clinical Research; Diseases; Economic Factors; Hiv Infections; Immunity; Immunologic Factors; Immunological Effects; Literature Review; Physiology; Research And Development; Research Methodology; Technology; Viral Diseases--etiology

Mesh：

Substances：

Year:  1984        PMID： 6208484     DOI： 10.1056/NEJM198411153112006

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  70 in total

1.  Structural and biochemical characterization of the inhibitor complexes of xenotropic murine leukemia virus-related virus protease.

Authors:  Mi Li; Alla Gustchina; Krisztina Matúz; Jozsef Tözsér; Sirilak Namwong; Nathan E Goldfarb; Ben M Dunn; Alexander Wlodawer
Journal:  FEBS J       Date:  2011-10-10       Impact factor: 5.542

2.  Differential susceptibility of human lymphocyte cultures to infection by HIV.

Authors:  M A Wainberg; N Blain; L Fitz-Gibbon
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

3.  Cultured human thymus epithelial monolayer cells induce CD4 expression on mononuclear cells of AIDS patients in vitro.

Authors:  H J Schuurman; R W Hendriks; J M Lange; J A van der Linden; F H Gmelig Meyling; S A Danner; L Kater
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

4.  Natural killer cells in intravenous drug abusers with lymphadenopathy syndrome.

Authors:  G Poli; M Introna; F Zanaboni; G Peri; M Carbonari; F Aiuti; A Lazzarin; M Moroni; A Mantovani
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

5.  Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2',3'-dideoxythymidine.

Authors:  X B Kong; Q Y Zhu; R M Ruprecht; K A Watanabe; J M Zeidler; J W Gold; B Polsky; D Armstrong; T C Chou
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

6.  Indirect immunofluorescence test performance and questionnaire results from the Centers for Disease Control Model Performance Evaluation Program for human immunodeficiency virus type 1 testing.

Authors:  R N Taylor; T L Hearn; W O Schalla; R O Valdiserri
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948

7.  Synthesis of functional human immunodeficiency virus tat protein in baculovirus as determined by a cell-cell fusion assay.

Authors:  K T Jeang; P R Shank; A B Rabson; A Kumar
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

8.  Monocyte function in intravenous drug abusers with lymphadenopathy syndrome and in patients with acquired immunodeficiency syndrome: selective impairment of chemotaxis.

Authors:  G Poli; B Bottazzi; R Acero; L Bersani; V Rossi; M Introna; A Lazzarin; M Galli; A Mantovani
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

9.  Thiazoline peptides and a tris-phenethyl urea from Didemnum molle with anti-HIV activity.

Authors:  Zhenyu Lu; Mary Kay Harper; Christopher D Pond; Louis R Barrows; Chris M Ireland; Ryan M Van Wagoner
Journal:  J Nat Prod       Date:  2012-07-30       Impact factor: 4.050

10.  Inhibition of HIV-1 entry by extracts derived from traditional Chinese medicinal herbal plants.

Authors:  In-Woo Park; Changri Han; Xiaoping Song; Linden A Green; Ting Wang; Ying Liu; Changchun Cen; Xinming Song; Biao Yang; Guangying Chen; Johnny J He
Journal:  BMC Complement Altern Med       Date:  2009-08-05       Impact factor: 3.659
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.